While Utah is so far the only state offering the AI renewals, Doctronic is reportedly in discussion to expand the practice to ...
The program is through the state’s “regulatory sandbox” framework, which allows businesses to trial “innovative” products or ...
A research team affiliated with UNIST has reported a new simulation tool to better understand how liquid-phase chemical ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...
Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
The filing comes about a month after competitor Medtronic won FDA approval for the Hugo robotic-assisted surgery system.
News-Medical.Net on MSN
CRISPR Cas12a3: A precise tool to halt viral protein production
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results